Molecular Neurodegeneration
Volume 1
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
  ReviewPathological and physiological functions of presenilinsKulandaivelu S Vetrivel1  , Yun-wu Zhang2 , Huaxi Xu2 and Gopal Thinakaran1  1Department of Neurobiology, Pharmacology and Physiology, The University of Chicago, Chicago, IL 60637, USA 2Center for Neuroscience and Aging, Burnham Institute for Medical Research, LaJolla, CA 92037, USA  author email corresponding author email
Molecular Neurodegeneration 2006,
1:4doi:10.1186/1750-1326-1-4 Abstract
Mutations in PSEN1 and PSEN2 genes account for the majority of cases of early-onset familial Alzheimer disease. Since the first prediction of a genetic link between PSEN1 and PSEN2 with Alzheimer's disease, many research groups from both academia and pharmaceutical industry have sought to unravel how pathogenic mutations in PSEN cause presenile dementia. PSEN genes encode polytopic membrane proteins termed presenilins (PS1 and PS2), which function as the catalytic subunit of γ-secretase, an intramembrane protease that has a wide spectrum of type I membrane protein substrates. Sequential cleavage of amyloid precursor protein by BACE and γ-secretase releases highly fibrillogenic β-amyloid peptides, which accumulate in the brains of aged individuals and patients with Alzheimer's disease. Familial Alzheimer's disease-associated presenilin variants are thought to exert their pathogenic function by selectively elevating the levels of highly amyloidogenic Aβ42 peptides. In addition to Alzheimer's disease, several recent studies have linked PSEN1 to familiar frontotemporal dementia. Here, we review the biology of PS1, its role in γ-secretase activity, and discuss recent developments in the cell biology of PS1 with respect to Alzheimer's disease pathogenesis. | 
on Google Scholar
